{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:56Z","timestamp":1793144036446,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017412","name":"Becton Dickinson and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ygyno.2023.04.022","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T19:12:10Z","timestamp":1683313930000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial"],"prefix":"10.1016","volume":"174","author":[{"given":"Mark H.","family":"Stoler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Parvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Yanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.04.022_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer--burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0015","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/ijc.32669","article-title":"Approaches to triage optimization in HPV primary screening: extended genotyping and p16\/Ki-67 dual-stained cytology-retrospective insights from ATHENA","volume":"146","author":"Stoler","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0055","first-page":"CD008587","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0060","author":"WHO WHO"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0065","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","article-title":"Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years","volume":"31","author":"Jin","year":"2016","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity human papillomavirus trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0080","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0085","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1172\/JCI57149","article-title":"The known unknowns of HPV natural history","volume":"121","author":"Gravitt","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/v9080229","article-title":"Targeting persistent human papillomavirus infection","volume":"9","author":"Shanmugasundaram","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/LGT.0000000000000524","article-title":"Incorporating stakeholder feedback in guidelines development for the management of abnormal cervical cancer screening tests","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >\/=21years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","article-title":"Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review","volume":"24","author":"Bonde","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12885-021-09126-3","article-title":"Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination","volume":"22","author":"Song","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >\/=25\u00a0years of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >\/=2\u00a0years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.33812","article-title":"Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: results from the IMPACT trial","volume":"150","author":"Wright","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamaoncol.2018.4270","article-title":"Five-year risk of cervical precancer following p16\/Ki-67 dual-stain triage of HPV-positive women","volume":"5","author":"Clarke","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12885-015-1411-x","article-title":"Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm","volume":"15","author":"Chang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000528931","article-title":"Overview of ancillary techniques in cervical cytology","volume":"67","author":"Olivas","year":"2023","journal-title":"Acta Cytol."},{"issue":"278","key":"10.1016\/j.ygyno.2023.04.022_bb0170","first-page":"e1","article-title":"The IMproving primary screening and colposcopy triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase","volume":"225","author":"Safaeian","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0175","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma","volume":"157","author":"Pirog","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0185","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases","volume":"27","author":"Pirog","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0190","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0195","article-title":"National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study","volume":"376","author":"Smith","year":"2022","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.ygyno.2023.04.022_bb0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-2735","article-title":"Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis","volume":"166","author":"Arbyn","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000573","article-title":"Human papillomavirus same genotype persistence and risk: a systematic review","volume":"25","author":"Bonde","year":"2021","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0210","doi-asserted-by":"crossref","first-page":"e00997","DOI":"10.1128\/JCM.00997-19","article-title":"Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population","volume":"57","author":"Wong","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0215","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1158\/1055-9965.EPI-22-0757","article-title":"Validation of BD Onclarity HPV assay on vaginal self-samples versus cervical samples using the VALHUDES protocol","volume":"31","author":"Latsuzbaia","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2023.04.022_bb0220","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/JCM.00550-17","article-title":"Prevalence of human papillomavirus in self-taken samples from screening nonattenders","volume":"55","author":"Lam","year":"2017","journal-title":"J. Clin. Microbiol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T20:52:10Z","timestamp":1715806330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":44,"alternative-id":["S0090825823002019"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.022","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Becton, Dickinson and Company. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}